Royal Bank of Canada
AIFF

Royal Bank of Canada’s Firefly Neuroscience AIFF Stock Holding History

Royal Bank of Canada’s Portfolio AIFF Stock Details AIFF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Sell
1
-40
-98% -$70 ﹤0.01% 7918
2026
Q1 		$0 Buy
41
+40
+4,000% +$50 ﹤0.01% 7819
2025
Q4 		$0 Hold
1
– – ﹤0.01% 7760
2025
Q3 		$0 Sell
1
-500
-100% -$1.42K ﹤0.01% 7621
2025
Q2 		$1K Sell
501
-2,000
-80% -$6.34K ﹤0.01% 6959
2025
Q1 		$10K Buy
2,501
+2,500
+250,000% +$11.5K ﹤0.01% 6173
2024
Q4 		$0 Sell
1
-22
-96% -$68 ﹤0.01% 7343
2024
Q3 		$0 Buy
23
+15
+188% +$79 ﹤0.01% 7582
2024
Q2 		$0 Hold
8
– – ﹤0.01% 7631
2024
Q1 		$0 Sell
8
-17
-68% -$114 ﹤0.01% 7706
2023
Q4 		$0 Hold
25
– – ﹤0.01% 7671
2023
Q3 		$0 Sell
25
-2
-7% -$20 ﹤0.01% 7695
2023
Q2 		$0 Buy
+27
New +$306 ﹤0.01% 7730
2022
Q4 		– Sell
-7
Closed – – 7815
2022
Q3 		$0 Buy
+7
New +$257 ﹤0.01% 7954

Other funds holding AIFF

M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCA
Cygnus Capital Advisors Atlanta, Georgia $147M AUM

Royal Bank of Canada's AIFF Position: Q2 2026 in Review

Royal Bank of Canada reduced its Firefly Neuroscience (AIFF) stake by 98% in Q2 2026, selling an estimated $70 and leaving 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7918.

Royal Bank of Canada first reported a position in AIFF in Q3 2022 and has held it in 14 quarters since. The position peaked at $10K in Q1 2025. 23 funds tracked by Wall St. Rank hold AIFF as of Q2 2026.

  • Royal Bank of Canada held 1 share of Firefly Neuroscience worth $0 as of Q2 2026.
  • Royal Bank of Canada sold 40 Firefly Neuroscience shares in Q2 2026, an estimated $70.
  • Firefly Neuroscience made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #7918 holding.
  • Royal Bank of Canada first reported a position in Firefly Neuroscience in Q3 2022 and has held it in 14 quarters since.
  • Royal Bank of Canada's Firefly Neuroscience position peaked at $10K in Q1 2025.
  • 23 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.